Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: Influence of sequence variation and levels of expression on the bactericidal immune response against meningococci

Infection and Immunity

Volumn 69, Issue 6, 2001, Pages 3809-3816

  Jolley, K A ^a   Appleby, L ^a   Wright, J C ^a   Christodoulides, M ^a   Heckels, J E ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; AMPHOLYTE; IMMUNOGLOBULIN; LIPOSOME; OUTER MEMBRANE PROTEIN; PHOSPHORYL LIPID A; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; BACTERICIDAL ACTIVITY; CELLULAR IMMUNITY; ENZYME IMMUNOASSAY; EXPRESSION VECTOR; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOFLUORESCENCE; MENINGOCOCCOSIS; MICELLE; MOLECULAR CLONING; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STRAIN DIFFERENCE;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BLOOD BACTERICIDAL ACTIVITY; CLONING, MOLECULAR; GENETIC VECTORS; IMMUNE SERA; IMMUNIZATION; LIPOSOMES; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

EID: 0035010024     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.6.3809-3816.2001     Document Type: Article

References (32)

1. Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup b meningococcal disease in Norway
2. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
3. Efficacy, safety, and immunogenicity of a meningococcal group B (15- P1.3) outer-membrane protein vaccine in Iquique, Chile
4. Sequence variation in class 1 outer membrane protein in Neisseria meningitidis isolated from patients with meningococcal infection and close household contacts
5. Immunisation with recombinant class 1 outer membrane protein from Neisseria meningitidis: Influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci
6. Immunisation with synthetic peptides containing epitopes of the class 1 outer membrane protein of Neisseria meningitidis: Production of bactericidal antibodies on immunisation with a cyclic peptide
7. Influence of adjuvants on the humoral immune response towards a synthetic peptide containing a B-cell epitope from meningococcal class 1 protein
8. Naturally occurring isolates of Neisseria gonorrhoeae, which display anomalous serovar properties, express PIA/PIB hybrid porins, deletions in PIB or novel PIA molecules
9. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil
10. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis
11. Human immunity to the meningococcus. I. The role of humoral antibodies
12. Human immunity to the meningococcus. II. Development of natural immunity
13. The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis
14. Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes
15. Point mutation in meningococcal porA gene associated with increased endemic disease
16. Two-dimensional structure of the Opc invasin from Neisseria meningitidis
17. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: Comparison with efficacy
18. Structural and functional characterization of a recombinant PorB class 2 protein from Neisseria meningitidis - Conformational stability and porin activity
19. Recombinant Opc meningococcal protein, folded in vitro, elicits bactericidal antibodies after immunization
20. The Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis and reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes
21. Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland
22. Expression of large amounts of neisserial porin proteins in Escherichia coli and refolding of the proteins into native trimers
23. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine
24. Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine
25. Allelic polymorphism and site-specific recombination in the opc locus of Neisseria meningitidis
26. Variation in the expression of pill and outer membrane protein by Neisseria meningitidis during the course of meningococcal infection
27. Topology of outer membrane porins in pathogenic Neisseria spp.
28. Adjuvant effects of liposomes containing lipid A - Enhancement of liposomal antigen presentation and recruitment of macrophages
29. Meningococcal Opa and Opc proteins: Their role in colonization and invasion of human epithelial and endothelial cells
30. Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis
31. Expression of Neisseria meningitidis class 1 porin as a fusion protein in Escherichia coli: The influence of liposomes and adjuvants on the production of a bactericidal immune response
32. Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I-adjuvant preparations